N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143907 |
| CAS No | NA |
| Mol.F. | C28H24N8O4 |
| Mol.Wt. | 507.55 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143908 |
| CAS No | NA |
| Mol.F. | C16H7N3O9S2 : 2Na |
| Mol.Wt. | 449.4 : 2(23.0) g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143909 |
| CAS No | NA |
| Mol.F. | C16H7N3O9S2 : 2(Na) |
| Mol.Wt. | 449.4 : 2(23.0)g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143910 |
| CAS No | NA |
| Mol.F. | C16H6N4O10S2 : 2(Na) |
| Mol.Wt. | 478.4 : 2(23.0) g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143911 |
| CAS No | NA |
| Mol.F. | C11H10N6O2 |
| Mol.Wt. | 258.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143912 |
| CAS No | NA |
| Mol.F. | C11H11N5O |
| Mol.Wt. | 229.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143913 |
| CAS No | NA |
| Mol.F. | C11H9N5O2 |
| Mol.Wt. | 243.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143914 |
| CAS No | NA |
| Mol.F. | C15H15Cl2N7O9S4 |
| Mol.Wt. | 636.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143915 |
| CAS No | 664985-71-1 |
| Mol.F. | C3H6N2O2 |
| Mol.Wt. | 102.1 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143916 |
| CAS No | 60391-92-6 |
| Mol.F. | C3H5N3O4 |
| Mol.Wt. | 147.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143917 |
| CAS No | NA |
| Mol.F. | C10H22N2O3 |
| Mol.Wt. | 218.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143918 |
| CAS No | NA |
| Mol.F. | C15H14N2O3 |
| Mol.Wt. | 270.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143919 |
| CAS No | NA |
| Mol.F. | C14H20N2O2 |
| Mol.Wt. | 248.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143920 |
| CAS No | 943-41-9 |
| Mol.F. | C7H7N3O3 |
| Mol.Wt. | 182.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143921 |
| CAS No | 60153-49-3 |
| Mol.F. | C4H7N3O |
| Mol.Wt. | 113.1g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143922 |
| CAS No | 51938-17-1 |
| Mol.F. | C6H12N2O3 |
| Mol.Wt. | 160.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |